{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:08Z","timestamp":1787027288991,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970641"],"award-info":[{"award-number":["81970641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD), a global health challenge, is closely linked to renal fibrosis progression. Copper, an essential trace element, influences cellular functions, yet its role in CKD-related fibrosis remains unclear. This study explores the causal relationship between serum copper levels and renal fibrosis in CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A two-sample Mendelian Randomization (MR) analysis integrated GWAS and FinnGen data. Serum copper and other metals were quantified via ICP-MS in 505 CKD patients and 50 controls. Renal fibrosis was histologically assessed in 168 biopsy-confirmed cases. Multivariable logistic regression and restricted cubic splines (RCS) evaluated associations between copper levels, renal function, and fibrosis severity, adjusting for demographics and biochemical parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MR confirmed causality between elevated copper and CKD risk. CKD patients had higher serum copper than controls (957.10\u202f\u00b1\u202f273.82 vs. 795.50\u202f\u00b1\u202f143.85\u202fng\/ml,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), with progressive increases from stage 1 to 5 (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). In biopsy-proven cases, severe fibrosis (&amp;gt;5%) correlated with higher copper levels and lower eGFR versus mild fibrosis (\u22645%). Adjusted analysis identified quartile 4 copper levels (&amp;gt;961.64\u202fng\/ml) as an independent predictor of severe fibrosis (OR\u202f=\u202f2.75, 95% CI: 1.06\u20137.16,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). RCS revealed non-linear relationships between copper, fibrosis (P for non-linear\u202f=\u202f0.038), and eGFR (P for non-linear\u202f=\u202f0.005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated serum copper is independently associated with renal fibrosis in CKD, suggesting copper dysregulation may contribute to fibrotic pathogenesis. These findings underscore the therapeutic potential of targeting copper metabolism to mitigate CKD progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1657180","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T05:26:34Z","timestamp":1756099594000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between copper exposure and renal fibrosis in patients with chronic kidney disease: evidence from Mendelian randomization and a retrospective study"],"prefix":"10.3389","volume":"13","author":[{"given":"Kaixiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"100438","DOI":"10.1016\/j.lanepe.2022.100438","article-title":"Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2.4 million patients from 11 countries: the CaReMe Ckd study","volume":"20","author":"Sundstrom","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/14728222.2020.1762173","article-title":"New therapeutic targets in chronic kidney disease progression and renal fibrosis","volume":"24","author":"Rayego-Mateos","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jot.2024.06.011","article-title":"The impact of copper on bone metabolism","volume":"47","author":"Zhang","year":"2024","journal-title":"J Orthop Translat"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fphys.2018.00105","article-title":"Oxidative stress and renal fibrosis: recent insights for the development of novel therapeutic strategies","volume":"9","author":"Lv","year":"2018","journal-title":"Front Physiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"F739","DOI":"10.1152\/ajprenal.00026.2024","article-title":"Commd5 counteracts cisplatin-induced nephrotoxicity by maintaining tubular epithelial integrity and autophagy flux","volume":"327","author":"Ogasawara-Nosoko","year":"2024","journal-title":"Am J Physiol Ren Physiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"C254","DOI":"10.1152\/ajpcell.00497.2023","article-title":"Cuproptosis associated cytoskeletal destruction contributes to podocyte injury in chronic kidney disease","volume":"327","author":"Li","year":"2024","journal-title":"Am J Phys Cell Phys"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/j.clnu.2022.10.016","article-title":"Association of copper exposure with prevalence of chronic kidney disease in older adults","volume":"41","author":"Guo","year":"2022","journal-title":"Clin Nutr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"163100","DOI":"10.1016\/j.scitotenv.2023.163100","article-title":"Association of urinary exposure to multiple metal(loid)s with kidney function from a national cross-sectional study","volume":"882","author":"Yu","year":"2023","journal-title":"Sci Total Environ"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"143467","DOI":"10.1016\/j.chemosphere.2024.143467","article-title":"Associations between multi-metal joint exposure and decreased estimated glomerular filtration rate (egfr) in solar greenhouse workers: a study of a unique farmer group","volume":"366","author":"Yan","year":"2024","journal-title":"Chemosphere"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.chemosphere.2019.03.171","article-title":"Association of plasma and urine metals levels with kidney function: a population-based cross-sectional study in China","volume":"226","author":"Yang","year":"2019","journal-title":"Chemosphere"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/nep.13089","article-title":"Prospective associations between environmental heavy metal exposure and renal outcomes in adults with chronic kidney disease","volume":"23","author":"Tsai","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/s41430-022-01181-8","article-title":"Relationship of serum copper and zinc with kidney function and urinary albumin to creatinine ratio: cross-sectional data from the Nhanes 2011-2016","volume":"76","author":"Jiang","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000181468","article-title":"Changes in copper and ceruloplasmin in chronic renal insufficiency treated by hemodialysis and peritoneal dialysis","volume":"22","author":"Bustamante","year":"1978","journal-title":"Nephron"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/nu14030509","article-title":"Genetically predicted circulating copper and risk of chronic kidney disease: a Mendelian randomization study","volume":"14","author":"Ahmad","year":"2022","journal-title":"Nutrients"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1440800","DOI":"10.3389\/fnut.2024.1440800","article-title":"Mendelian randomization analyses explore the effects of micronutrients on different kidney diseases","volume":"11","author":"Shi","year":"2024","journal-title":"Front Nutr"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamacardio.2023.4115","article-title":"Mendelian randomization as a tool for cardiovascular research: a review","volume":"9","author":"Levin","year":"2024","journal-title":"JAMA Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"Kdigo 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"339905","DOI":"10.1016\/j.aca.2022.339905","article-title":"An improved calibrated mass spectrometry for absolute copper isotope-ratio measurement using two strategies for mass bias correction factor","volume":"1211","author":"Song","year":"2022","journal-title":"Anal Chim Acta"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"156066","DOI":"10.1016\/j.phymed.2024.156066","article-title":"Imperatorin ameliorates ferroptotic cell death, inflammation, and renal fibrosis in a unilateral ureteral obstruction mouse model","volume":"135","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2319712","DOI":"10.1080\/0886022X.2024.2319712","article-title":"Recent advances in the application of Mendelian randomization to chronic kidney disease","volume":"46","author":"Wen","year":"2024","journal-title":"Ren Fail"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e08382","DOI":"10.1016\/j.heliyon.2021.e08382","article-title":"Status of metals in serum and urine samples of chronic kidney disease patients in a rural area of Bangladesh: an observational study","volume":"7","author":"Choudhury","year":"2021","journal-title":"Heliyon"},{"key":"ref28","first-page":"69","article-title":"Zinc and copper concentration in plasma and erythrocytes of patients with chronic renal failure","volume":"12","author":"Paniagua-Sierra","year":"1981","journal-title":"Arch Invest Med (Mex)"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/ajcn\/47.5.896","article-title":"Elevated plasma copper in chronic renal failure","volume":"47","author":"Sondheimer","year":"1988","journal-title":"Am J Clin Nutr"},{"key":"ref30","first-page":"35","article-title":"The trace elements zinc and copper in chronic renal failure","volume":"81","author":"Prehn","year":"1988","journal-title":"Z Urol Nephrol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1039510","DOI":"10.3389\/fimmu.2022.1039510","article-title":"Appropriate level of cuproptosis may be involved in alleviating pulmonary fibrosis","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00018-024-05358-1","article-title":"Mitochondrial copper overload promotes renal fibrosis via inhibiting pyruvate dehydrogenase activity","volume":"81","author":"Zhu","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated Tca cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s12013-024-01379-6","article-title":"Quercetin attenuates acute kidney injury caused by cisplatin by inhibiting Ferroptosis and Cuproptosis","volume":"82","author":"Shi","year":"2024","journal-title":"Cell Biochem Biophys"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41419-020-2404-5","article-title":"Elevated intracellular copper contributes a unique role to kidney fibrosis by lysyl oxidase mediated matrix crosslinking","volume":"11","author":"Niu","year":"2020","journal-title":"Cell Death Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/biof.1837","article-title":"Copper chelation therapy inhibits renal fibrosis by modulating copper transport proteins","volume":"48","author":"Saifi","year":"2022","journal-title":"Biofactors"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"700902","DOI":"10.3389\/fphar.2021.700902","article-title":"Tetrathiomolybdate treatment attenuates bleomycin-induced angiogenesis and lung pathology in a sheep model of pulmonary fibrosis","volume":"12","author":"Derseh","year":"2021","journal-title":"Front Pharmacol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1657180\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T05:26:35Z","timestamp":1756099595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1657180\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":37,"alternative-id":["10.3389\/fpubh.2025.1657180"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1657180","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"article-number":"1657180"}}